CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Adjusted EPS | ₹24.43 | ₹14.80 | ₹13.89 | ₹13.89 |
What is the latest Earnings Per Share (EPS) of CORONA REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹24.43 |
| Mar2025 | ₹14.80 |
| Mar2024 | ₹13.89 |
| Mar2023 | ₹13.89 |
How is Earnings Per Share (EPS) of CORONA REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹24.43 | 65.07 | |
| Mar2025 | ₹14.80 | 6.55 | |
| Mar2024 | ₹13.89 | 0.00 | |
| Mar2023 | ₹13.89 | - | |
Compare Earnings Per Share (EPS) of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,556.1 Cr | 7.8% | 7.8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 7.8% |
7.8% |
|
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses